Prot #BBT877-IPF-004: A Phase 2, Randomized, Double-blind, Placebo-controlled, 24-Week Study to Evaluate the Efficacy, Safety, and Tolerability of BBT-877, as Mono-or Add-on Therapy, in Patients with Idiopathic Pulmonary Fibrosis (IPF)

Project: Research project

Project Details

StatusActive
Effective start/end date12/15/22 → 12/15/25

Funding

  • PPD Investigator Services, LLC (Prot #BBT877-IPF-004)
  • Bridge Biotherapeutics, Inc. (Prot #BBT877-IPF-004)